Abstract
An 8 year-old boy with X-ALD under treatment with simvastatin developed a severe adverse reaction when the dose of his other medication, zuclopenthixol was increased. Both drugs were withdrawn after a diagnosis of neuroleptic malignant syndrome was made.
Similar content being viewed by others
REFERENCES
Deslypere JP, Vermeulen A (1991) Rhabdomyolysis and simvastatin. Ann Intern Med 114: 342.
Gurrera RJ (1999) Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry 156: 169-180.
Verrips A, Willemsen MA, Rubio-Gozalbo E, De Jong J, Smeitink JA (2000) Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy. Ann Neurol 47: 552-553.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubio-Gozalbo, M.E., van Waardenburg, D.A., Forget, P.P. et al. Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy. J Inherit Metab Dis 24, 605–606 (2001). https://doi.org/10.1023/A:1012480130445
Issue Date:
DOI: https://doi.org/10.1023/A:1012480130445